Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)

BACKGROUND: Glucagon-like peptide-1 receptor (GLP-1R) agonists improve cardiovascular outcomes in patients with type 2 diabetes mellitus. However, systemic actions of these agents cause sympathetic activation, which is generally considered to be detrimental in cardiovascular disease. Despite signifi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Circ Arrhythm Electrophysiol
Autori principali: Ang, Richard, Mastitskaya, Svetlana, Hosford, Patrick S., Basalay, Marina, Specterman, Mark, Aziz, Qadeer, Li, Yiwen, Orini, Michele, Taggart, Peter, Lambiase, Pier D., Gourine, Andrey, Tinker, Andrew, Gourine, Alexander V.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553567/
https://ncbi.nlm.nih.gov/pubmed/30354404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.118.006740
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi